NANOS1 and breast cancer: Indeed, Kaplan–Meier (KM) analysis of breast cancer patients, using median expression of NANOS1, PUM2, AND CPFS4 as a signature, revealed significant stratification of distant metastasis-free survival (DMFS) in patients with the basal subtype (Fig. 1b).